Close

Dr Aurelien Belot

Honorary Associate Professor

United Kingdom

Affiliations

Department of Non-communicable Disease Epidemiology
Faculty of Epidemiology and Population Health

Centres

Centre for Data and Statistical Science for Health

Selected Publications

On models for the estimation of the excess mortality hazard in case of insufficiently stratified life tables.
Rubio, FJ; RACHET, B; Giorgi, R; MARINGE, C; BELOT, A;
2019
Biostatistics
Summarizing and communicating on survival data according to the audience: a tutorial on different measures illustrated with population-based cancer registry data.
BELOT, A; Ndiaye, A; LUQUE-FERNANDEZ, M-A; KIPOUROU, D-K; MARINGE, C; Rubio, FJ; RACHET, B;
2019
CLINICAL EPIDEMIOLOGY
On a general structure for hazard-based regression models: An application to population-based cancer research.
Rubio, FJ; Remontet, L; JEWELL, NP; BELOT, A;
2018
Statistical methods in medical research
A multilevel excess hazard model to estimate net survival on hierarchical data allowing for non-linear and non-proportional effects of covariates.
Charvat, H; Remontet, L; Bossard, N; Roche, L; Dejardin, O; RACHET, B; Launoy, G; BELOT, A; CENSUR Working Survival Group,;
2016
Statistics in medicine
Incidence and prevalence of obstructive sleep apnoea and narcolepsy in the UK: a population-based descriptive study.
STRONGMAN, H; Sykorova, M; Yu, YT N; BELOT, A; Mistry, H; NOLTE, E; Eriksson, SH; Miller, MA; BHASKARAN, K; Smith, IE; WARREN-GASH, C;
2026
Thorax
Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV.
Grabar, S; Lakrout, P; Potard, V; BELOT, A; Cadranel, J; Jacomet, C; Katlama, C; Marshall, E; Lambotte, O; Palich, R; Ronot-Bregigeon, S; Spano, J-P; Bouvier, A-M; Makinson, A; Costagliola, D;
2025
International journal of cancer
Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.
Letailleur, V; Chaillol, I; Cherblanc, F; Ghesquières, H; Peyrade, F; Guidez, S; Bijou, F; Sesques, P; Rossi, C; Fornecker, L-M; Fouillet, L; Carras, S; Chartier, L; BELOT, A; Oberic, L; Jardin, F; Tessoulin, B;
2025
Blood cancer journal
Impact of socioeconomic individual and ecological factors on extreme diagnosis-to-treatment interval in diffuse large B-Cell lymphoma in the French real-world cohort REALYSA.
Cantrelle, C; BELOT, A; Monnereau, A; Bijou, F; Rossi, C; Bommier, C; Hafirassou, HK; Fouillet, L; Ghesquières, H; Ysebaert, L; Le Guyader Peyrou, S;
2025
Cancer epidemiology
See more information